232 related articles for article (PubMed ID: 26345967)
1. Integrated microRNA-mRNA analysis of pancreatic ductal adenocarcinoma.
Liu PF; Jiang WH; Han YT; He LF; Zhang HL; Ren H
Genet Mol Res; 2015 Aug; 14(3):10288-97. PubMed ID: 26345967
[TBL] [Abstract][Full Text] [Related]
2. Identification of miRNA-mRNA crosstalk in pancreatic cancer by integrating transcriptome analysis.
Yang J; Zeng Y
Eur Rev Med Pharmacol Sci; 2015; 19(5):825-34. PubMed ID: 25807437
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.
Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S
Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086
[TBL] [Abstract][Full Text] [Related]
4. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
[TBL] [Abstract][Full Text] [Related]
5. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
[TBL] [Abstract][Full Text] [Related]
6. Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma.
Liu Q; Chen J; Wang J; Amos C; Killary AM; Sen S; Wei C; Frazier ML
Mol Carcinog; 2014 Sep; 53(9):711-21. PubMed ID: 23661430
[TBL] [Abstract][Full Text] [Related]
7. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
Liu M; Zhu K; Qian X; Li W
Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of mRNA and miRNA expression profiles in pancreatic ductal adenocarcinoma.
Sun H; Zhao L; Pan K; Zhang Z; Zhou M; Cao G
Oncol Rep; 2017 May; 37(5):2779-2786. PubMed ID: 28339085
[TBL] [Abstract][Full Text] [Related]
9. Construction of a circRNA-miRNA-mRNA network to explore the pathogenesis and treatment of pancreatic ductal adenocarcinoma.
Xiao Y
J Cell Biochem; 2020 Jan; 121(1):394-406. PubMed ID: 31232492
[TBL] [Abstract][Full Text] [Related]
10. An Integrated Data Analysis of mRNA, miRNA and Signaling Pathways in Pancreatic Cancer.
Sohrabi E; Rezaie E; Heiat M; Sefidi-Heris Y
Biochem Genet; 2021 Oct; 59(5):1326-1358. PubMed ID: 33813720
[TBL] [Abstract][Full Text] [Related]
11. Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Hepatocellular Carcinoma by Integrated Microarray Analysis.
Lin X; Chen Y
Med Sci Monit Basic Res; 2018 Apr; 24():70-78. PubMed ID: 29706616
[TBL] [Abstract][Full Text] [Related]
12. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
[TBL] [Abstract][Full Text] [Related]
13. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
Giulietti M; Occhipinti G; Principato G; Piva F
Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
[TBL] [Abstract][Full Text] [Related]
14. Identification of the miRNA-mRNA regulatory network in multiple sclerosis.
Yang Q; Pan W; Qian L
Neurol Res; 2017 Feb; 39(2):142-151. PubMed ID: 27809691
[TBL] [Abstract][Full Text] [Related]
15. Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis.
Van der Goten J; Vanhove W; Lemaire K; Van Lommel L; Machiels K; Wollants WJ; De Preter V; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Schuit F; Vermeire S; Arijs I
PLoS One; 2014; 9(12):e116117. PubMed ID: 25546151
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.
Szafranska AE; Davison TS; John J; Cannon T; Sipos B; Maghnouj A; Labourier E; Hahn SA
Oncogene; 2007 Jun; 26(30):4442-52. PubMed ID: 17237814
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.
Nakata K; Ohuchida K; Mizumoto K; Kayashima T; Ikenaga N; Sakai H; Lin C; Fujita H; Otsuka T; Aishima S; Nagai E; Oda Y; Tanaka M
Surgery; 2011 Nov; 150(5):916-22. PubMed ID: 22018284
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma.
Felix TF; Lopez Lapa RM; de Carvalho M; Bertoni N; Tokar T; Oliveira RA; M Rodrigues MA; Hasimoto CN; Oliveira WK; Pelafsky L; Spadella CT; Llanos JC; F Silva G; Lam WL; Rogatto SR; Amorim LS; Drigo SA; Carvalho RF; Reis PP
PLoS One; 2019; 14(5):e0217421. PubMed ID: 31150430
[TBL] [Abstract][Full Text] [Related]
19. EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas.
Mees ST; Mardin WA; Wendel C; Baeumer N; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Int J Cancer; 2010 Jan; 126(1):114-24. PubMed ID: 19569050
[TBL] [Abstract][Full Text] [Related]
20. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value.
Namkung J; Kwon W; Choi Y; Yi SG; Han S; Kang MJ; Kim SW; Park T; Jang JY
J Gastroenterol Hepatol; 2016 Jun; 31(6):1160-7. PubMed ID: 26644397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]